Director / Senior Director, Pharmacology

Cambridge, MA

Generation Bio is a biotechnology company changing what is possible for people living with T cell-driven autoimmune diseases. The company is developing novel therapeutics leveraging its T cell selective cell-targeted lipid nanoparticle (ctLNP) to deliver siRNA in vivo, enabling modulation of T cell activity that causes inflammation and auto-reactive tissue destruction. By selectively modulating T cells that drive disease pathology, ctLNP-siRNA therapeutics could potently block target function with sequence-level specificity while sparing the broader immune system. This potent new modality is designed to reach targets that are poorly drugged by other approaches, opening a broad indication space of T cell driven autoimmune diseases.

We are a thriving, collaborative, creative community of 100 people with diverse talents, beliefs, and experiences headquartered in Cambridge, Massachusetts.  

Delve further.  Please visit www.generationbio.com or follow @generationbio. To see additional roles, please also check out https://generationbio.com/careers/ 

SUMMARY: 

Generation Bio seeks an energetic and highly motivated (Sr) Director to join the preclinical team and lead our pharmacology function. This highly visible position will lead a team of scientists to drive platform and translational pharmacology research. This role will develop and execute a pre-clinical strategy to advance our ctLNP platform, and work closely with our discovery research and program teams to develop translational models and bioassays to advance our pipeline of T cell siRNA programs.

The ideal candidate will have a strong background in research and development of immune-modulating therapies, with experience developing bioassays and biomarkers to characterize drug pharmacology in early development. The successful candidate will move seamlessly between managing in-vivo studies as well as demonstrating a strong commitment to leading and developing a team of scientists performing lab-based work to develop animal models, biomarkers, and new bioassays.  The position will partner closely with cross-functional colleagues across Research, Analytical Development, and Non-Clinical Development to deliver on the company objectives. 

 
RESPONSIBILITIES:  

  • Build, support, and lead a team of scientists to design and execute mechanistic and translational studies as well as develop assays to characterize siRNA mediated inhibition and associated immunological effects in T-cells.
  • Develop, characterize, and evaluate animal disease models.
  • Work with non-clinical development and regulatory teams to optimize, validate and transfer key bioassays for IND-enabling and clinical studies
  • Collaborate with internal and external partners to provide strategic pharmacology guidance, plan, and execute studies to support preclinical and clinical drug development.
  • Serve as a subject matter expert to project teams via functional representation, and advise on regulatory submissions, and author regulatory documents from FIH through registrational filing.
  • Interface externally with CRO(s), collaborators, and potential research partners.
  • Summarize studies in written reports and oral presentations.
  • Review literature to identify relevant technologies and models.
  • Participate in due diligence and business development activities as needed.

 

QUALIFICATIONS:  

  • Ph.D. in Pharmacology, Immunology, Molecular/Cell Biology, or related field, with a minimum of 7 years of relevant experience. M.Sc. with a minimum of 10 years relevant experience, industry experience is required 
  • Experience in autoimmune diseases and T-cell biology or a background in tumor immunology.
  • Demonstrated leadership capabilities and the ability to lead and motivate team members and reinforces a positive and inclusive team culture that encourages growth and development.
  • Proven ability to develop strong relationships with internal and external partners to deliver on key objectives while nurturing a collaborative, innovative, and inclusive work environment.
  • Excellent lab technique and the ability to work independently to design experiments and analyze, interpret, and present data.
  • Proficient in protein and DNA/RNA detection and quantification (ELISA, western, RT-qPCR), cell-based imaging/flow cytometry (IHC, FACS), and activity assays (T-cell activation/killing assays, co-culture).
  • Proficient in in vivo/ex vivo sample and tissue preparation for flow cytometry/IHC based characterization.
  • Proactive thinking and ability to multi-task to support multiple projects across platform and disease biology pharmacology.
  • Demonstrated ability to analyze complex situations, identify critical issues, and develop proactive strategic solutions.
  • Experience authoring regulatory submissions and responses preferred.
  • Ability to work in a highly collaborative, team-based environment, with the ability to influence change across different stakeholder groups to drive business objectives.
  • Excellent written and verbal communication skills.

POSITION: Full-Time, Exempt 

EEOC Statement: Generation Bio believes in a diverse environment and is committed to equal employment opportunity for all its employees and qualified applicants. We do not discriminate in recruitment, hiring, training, promotion or any other employment practices for reasons of race (to include traits historically associated with race including, but not limited to, hair texture, hair type, hair length, and protective hairstyles such as braids, locks, twists, hair coverings, and Bantu knots), color, gender, religion, national origin, gender identity, age, sexual orientation, marital or veteran status, disability, or any other legally protected status. Generation Bio will make reasonable accommodations for qualified individuals with known disabilities, in accordance with applicable law.

Apply for this job

*

indicates a required field

Resume/CV

Accepted file types: pdf, doc, docx, txt, rtf

Cover Letter

Accepted file types: pdf, doc, docx, txt, rtf

Education

Select...
Select...
Select...
Select...
Select...

Voluntary Self-Identification

For government reporting purposes, we ask candidates to respond to the below self-identification survey. Completion of the form is entirely voluntary. Whatever your decision, it will not be considered in the hiring process or thereafter. Any information that you do provide will be recorded and maintained in a confidential file.

As set forth in Generation Bio’s Equal Employment Opportunity policy, we do not discriminate on the basis of any protected group status under any applicable law.

Select...
Select...
Race & Ethnicity Definitions

If you believe you belong to any of the categories of protected veterans listed below, please indicate by making the appropriate selection. As a government contractor subject to the Vietnam Era Veterans Readjustment Assistance Act (VEVRAA), we request this information in order to measure the effectiveness of the outreach and positive recruitment efforts we undertake pursuant to VEVRAA. Classification of protected categories is as follows:

A "disabled veteran" is one of the following: a veteran of the U.S. military, ground, naval or air service who is entitled to compensation (or who but for the receipt of military retired pay would be entitled to compensation) under laws administered by the Secretary of Veterans Affairs; or a person who was discharged or released from active duty because of a service-connected disability.

A "recently separated veteran" means any veteran during the three-year period beginning on the date of such veteran's discharge or release from active duty in the U.S. military, ground, naval, or air service.

An "active duty wartime or campaign badge veteran" means a veteran who served on active duty in the U.S. military, ground, naval or air service during a war, or in a campaign or expedition for which a campaign badge has been authorized under the laws administered by the Department of Defense.

An "Armed forces service medal veteran" means a veteran who, while serving on active duty in the U.S. military, ground, naval or air service, participated in a United States military operation for which an Armed Forces service medal was awarded pursuant to Executive Order 12985.

Select...

Voluntary Self-Identification of Disability

Form CC-305
Page 1 of 1
OMB Control Number 1250-0005
Expires 04/30/2026

Why are you being asked to complete this form?

We are a federal contractor or subcontractor. The law requires us to provide equal employment opportunity to qualified people with disabilities. We have a goal of having at least 7% of our workers as people with disabilities. The law says we must measure our progress towards this goal. To do this, we must ask applicants and employees if they have a disability or have ever had one. People can become disabled, so we need to ask this question at least every five years.

Completing this form is voluntary, and we hope that you will choose to do so. Your answer is confidential. No one who makes hiring decisions will see it. Your decision to complete the form and your answer will not harm you in any way. If you want to learn more about the law or this form, visit the U.S. Department of Labor’s Office of Federal Contract Compliance Programs (OFCCP) website at www.dol.gov/ofccp.

How do you know if you have a disability?

A disability is a condition that substantially limits one or more of your “major life activities.” If you have or have ever had such a condition, you are a person with a disability. Disabilities include, but are not limited to:

  • Alcohol or other substance use disorder (not currently using drugs illegally)
  • Autoimmune disorder, for example, lupus, fibromyalgia, rheumatoid arthritis, HIV/AIDS
  • Blind or low vision
  • Cancer (past or present)
  • Cardiovascular or heart disease
  • Celiac disease
  • Cerebral palsy
  • Deaf or serious difficulty hearing
  • Diabetes
  • Disfigurement, for example, disfigurement caused by burns, wounds, accidents, or congenital disorders
  • Epilepsy or other seizure disorder
  • Gastrointestinal disorders, for example, Crohn's Disease, irritable bowel syndrome
  • Intellectual or developmental disability
  • Mental health conditions, for example, depression, bipolar disorder, anxiety disorder, schizophrenia, PTSD
  • Missing limbs or partially missing limbs
  • Mobility impairment, benefiting from the use of a wheelchair, scooter, walker, leg brace(s) and/or other supports
  • Nervous system condition, for example, migraine headaches, Parkinson’s disease, multiple sclerosis (MS)
  • Neurodivergence, for example, attention-deficit/hyperactivity disorder (ADHD), autism spectrum disorder, dyslexia, dyspraxia, other learning disabilities
  • Partial or complete paralysis (any cause)
  • Pulmonary or respiratory conditions, for example, tuberculosis, asthma, emphysema
  • Short stature (dwarfism)
  • Traumatic brain injury
Select...

PUBLIC BURDEN STATEMENT: According to the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless such collection displays a valid OMB control number. This survey should take about 5 minutes to complete.